Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems

Area of Science:

• Pharmacology and Pharmaceutical Sciences
• Analytical Chemistry
• Biotechnology

Background:

• Epirubicin (EPI), an anthracycline chemotherapy, treats tumors by inhibiting DNA/RNA synthesis.
• EPI therapy presents significant side effects, including cardiotoxicity and myelosuppression.
• Nanosystem drug delivery offers a strategy to enhance EPI's safety and efficacy.

Purpose of the Study:

• To review the physicochemical and pharmacokinetic properties of Epirubicin.
• To explore the application of Epirubicin in drug delivery nanosystems.
• To summarize analytical methods for quantifying Epirubicin in diverse matrices.

Main Methods:

• Literature review of Epirubicin's properties and applications.
• Analysis of analytical techniques for Epirubicin quantification.
• Focus on spectrophotometric, spectrofluorimetric, and chromatographic methods.

Main Results:

• Epirubicin's mechanism involves DNA/RNA synthesis suppression via intercalation.
• Nanosystems show promise for targeted EPI delivery, mitigating side effects.
• Spectrophotometry/spectrofluorimetry are efficient for simple matrices; HPLC excels in complex ones like plasma and urine.

Conclusions:

• Analytical methods are vital for characterizing EPI nanosystems.
• HPLC offers high sensitivity for EPI detection in biological fluids.
• This review provides a comprehensive overview for advancing EPI-based nanomedicine.